Dried blood spot samples for seroepidemiology of infections with human papillomaviruses, Helicobacter pylori, hepatitis C virus, and JC virus

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 2, 2012, Pages 287-293

  Waterboer, Tim ^a   Dondog, Bolormaa ^a,b   Michael, Kristina M ^a   Michel, Angelika ^a   Schmitt, Markus ^a   Vaccarella, Salvatore ^b   Franceschi, Silvia ^b   Clifford, Gary ^b   Pawlita, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; DNA VIRUS INFECTION; DRIED BLOOD SPOT TESTING; FEMALE; FILTER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; JC VIRUS; MAJOR CLINICAL STUDY; MONGOLIA; NEOPLASM; PRIORITY JOURNAL; RISK FACTOR; SEROEPIDEMIOLOGY; SERUM; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DRIED BLOOD SPOT TESTING; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPACIVIRUS; HEPATITIS C; HUMANS; JC VIRUS; MIDDLE AGED; MONGOLIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYOMAVIRUS INFECTIONS; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; SPECIMEN HANDLING; VIRUS DISEASES; YOUNG ADULT;

EID: 84857076046     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-1001     Document Type: Article

References (21)

1. Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol 1999;52:633-9. (Pubitemid 29456898)
2. Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, et al. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008;17:1731-8.
3. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, et al. Multiplex human papillomavirus serology based on in situpurified glutathione S-transferase fusion proteins. Clin Chem 2005; 51:1845-53. (Pubitemid 41368175)
4. Clifford GM, Shin HR, Oh JK, Waterboer T, Ju YH, Vaccarella S, et al. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev 2007;16:1874-9. (Pubitemid 47450520)
5. Kjaerheim K, Roe OD, Waterboer T, Sehr P, Rizk R, Dai HY, et al. Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 2007;120:2459-65. (Pubitemid 46642135)
6. Antonsson A, Green AC, Mallitt KA, O'Rourke PK, Pawlita M, Waterboer T, et al. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol 2010;91:1849-53.
7. Michel A, Waterboer T, Kist M, Pawlita M. Helicobacter pylori multiplex serology. Helicobacter 2009;14:525-35.
8. Sehr P, Zumbach K, Pawlita M. A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 2001;253:153-62. (Pubitemid 32522523)
9. Waterboer T, Sehr P, Pawlita M. Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 2006;309:200-4. (Pubitemid 43190816)
10. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2.
11. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007;117:60-9. (Pubitemid 46048450)
12. Berger JR. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J Neurovirol 2003;9 Suppl 1:38-41. (Pubitemid 36656469)
13. zur Hausen H. Viruses in human cancers. Eur J Cancer 1999;35: 1878-85.
14. Malaty HM, Nyren O. Epidemiology of Helicobacter pylori infection. Helicobacter 2003;8 Suppl 1:8-12. (Pubitemid 37295399)
15. Vaccarella S, Franceschi S, Clifford GM, Touze A, Hsu CC, de Sanjose S, et al. Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010;19:2379-88.
16. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 2007;96: 1127-34. (Pubitemid 46608308)
17. Dondog B, Lise M, Dondov O, Baldandorj B, Franceschi S. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Eur J Cancer Prev 2011;20:33-9.
18. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006;577:19-45.
19. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
20. Judd A, Parry J, Hickman M, McDonald T, Jordan L, Lewis K, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003;71:49-55. (Pubitemid 37121912)
21. Kaufmann AM, Nieland JD, Jochmus I, Baur S, Friese K, Gabelsberger J, et al. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int J Cancer 2007;121:2794-800. (Pubitemid 350136429)